Patents by Inventor Daniel Boyd Brown

Daniel Boyd Brown has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quetiapine granules
    Patent number: 7022692
    Abstract: Granule formulation of quetiapine and pharmaceutically acceptable salt thereof are described, as are their preparation and their use in treating diseases of the central nervous system such as psychotic disease conditions including schizophrenia.
    Type: Grant
    Filed: July 25, 2003
    Date of Patent: April 4, 2006
    Assignee: AstraZeneca AB
    Inventor: Daniel Boyd Brown
  • Formulation
    Publication number: 20040228914
    Abstract: Granule formulation of quetiapine and pharmaceutically acceptable salt thereof are described, as are their preparation and their use in treating diseases of the central nervous system such as psychotic disease conditions including schizophrenia.
    Type: Application
    Filed: July 25, 2003
    Publication date: November 18, 2004
    Inventor: Daniel Boyd Brown
  • Quetiapine granules
    Patent number: 6599897
    Abstract: Granule formulations of quetiapine and pharmaceutically acceptable salts thereof are described, as are their preparation and their use in treating diseases of the central nervous system such as psychotic disease conditions including schizophrenia.
    Type: Grant
    Filed: March 21, 2002
    Date of Patent: July 29, 2003
    Assignee: AstraZeneca AB
    Inventor: Daniel Boyd Brown